NEW YORK (GenomeWeb) – Contextual Genomics and the Personalized Medicine Initiative today announced that Pfizer Canada has joined the National Access Project for Cancer Testing.

Pfizer Canada has provided a grant of an undisclosed amount and technical support as part of its commitment to the consortium, whose goal is to provide genomic testing to all Canadians diagnosed with cancer and to accelerate a personalized approach to treating the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.